The role of protein tyrosine phosphorylation in the cell–cell junctions and intercellular permeability of post-confluent bovine corneal epithelial cells  by Chen, Yan-Ming et al.
at SciVerse ScienceDirect
Taiwan Journal of Ophthalmology 3 (2013) 37e41Contents lists availableTaiwan Journal of Ophthalmology
journal homepage: www.e-t jo.comOriginal articleThe role of protein tyrosine phosphorylation in the cellecell junctions
and intercellular permeability of post-conﬂuent bovine corneal
epithelial cellsYan-Ming Chen a,b,e, I-Hua Tu a,e, Fung-Rong Hu a,c, Chung-Tien Lin d, Wei-Li Chen a,c,*
aDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
bDepartment of Ophthalmology, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan
cCenter of Corneal Tissue Engineering and Stem Cell Biology, National Taiwan University Hospital, Taipei, Taiwan
dDepartment of Veterinary Medicine, College of Bio-Resource and Agriculture, National Taiwan University, Taipei, Taiwana r t i c l e i n f o
Article history:
Received 27 July 2012
Received in revised form
3 October 2012
Accepted 30 October 2012






vanadate* Corresponding author. Department of Ophthalm
versity Hospital, 7 Chung-Shan South Road, Taipei, Ta
E-mail address: chenweili@ntu.edu.tw (W.-L. Chen
e Y.-M.C. and I.-H.T. contributed equally to this arti
2211-5056/$ e see front matter Copyright  2013, Th
http://dx.doi.org/10.1016/j.tjo.2012.12.007a b s t r a c t
Purpose: To evaluate the role of protein tyrosine phosphatase (PTP) in controlling the integrity of cellecell
junction and intercellular permeability in postconﬂuent bovine corneal epithelial cells.
Methods: Conﬂuent cultures of bovine corneal epithelial cells were treated with different concentrations
of general phosphate inhibitors andsodium orthovanadate for varying periods. An MTS assay was used to
conﬁrm no cellular death under the treatment proﬁle. Immunocytochemical (ICC) analysis was per-
formed to demonstrate protein tyrosine phosphorylation after treatment with sodium orthovanadate,
and the effect of sodium orthovanadate on junctional proteins such as p120, a-catenin, occludin, ZO-1,
and ZO-2. Western blot analysis was used to analyze the changes in p120, a-catenin, occludin, ZO-1,
and ZO-2 after treatment. Paracellular permeability was evaluated by transepithelial electrical resist-
ance (TER).
Results: During the whole course of treatment, no signiﬁcant cellular death was noticed. Dose- and time-
dependent effects of sodium orthovanadate on protein tyrosine phosphorylation were conﬁrmed by ICC.
ICC also demonstrated the dose- and time-dependent effect of sodium orthovanadate on the disruption
of p120, a-catenin, occludin, ZO-1, and ZO-2. However, results of Western blot analysis showed no change
in the expression levels of p120, a-catenin, occludin, ZO-1, and ZO-2. Dose- and time-dependent increase
of paracellular permeability was evaluated by TER.
Conclusion: Inhibition of protein tyrosine phosphatase activity can increase protein tyrosine phosphor-
ylation. A dose- and time-dependent release of cellecell contacts and increased transepithelial perme-
ability were found in postconﬂuent culture of bovine corneal epithelial cells.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Corneal epithelium, a multilayered stratiﬁed squamous epi-
thelial sheet, provides the ﬁrst-line defense against invasion of al-
lergens, toxins, and pathogens.1e3 In addition, the barrier function
of corneal epithelium also controls the movement of ﬂuid into
corneal stroma and is associated with corneal transparency.46
Hypoxia, chemical damage, and dryness disrupt corneal epithelial
barrier function, resulting in corneal edema and impaired




e Ophthalmologic Society of TaiwThe barrier function of corneal epithelium is owing to the
presence of intracellular junctional proteins between adjacent
epithelial cells, such as tight junction and adherens junction pro-
teins.7,10 Tight junctions, located on the apical-most lateral mem-
branes, contains transmembrane proteins, occludin and claudin,
and associated proteins, such as ZO-1, ZO-2, and ZO-3. These tight
junction proteins contribute tomajor intracellular connecting force.
Adherens proteins include transmembrane proteins and cadherin,
which connect with actin cytoskeleton through associated proteins,
such as a, b, and g-catenin. Adherens proteins not only connect
with adjacent epithelial cells, but also play an important role in
maintaining the stability of cell skeleton and normal epithelial
morphology.10
Protein tyrosine phosphatases (PTPs) are enzymes that catalyze
the dephosphorylation of tyrosine-phosphorylated proteins.1114an. Published by Elsevier Taiwan LLC. All rights reserved.
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naling triggered by receptor tyrosine kinase. It is known that the
PTPs constitute a very large family of phosphatases, which can be
broadly classiﬁed into transmembrane, receptor-like, and non-
transmembrane, or nonreceptor PTPs. They are differentiated by
their noncatalytic segments, which are important for their cellular
targeting. The effects of phosphorylation on regulating cellular
proliferation, migration, differentiation, and junctional integrity of
corneal endothelial cells have been reported.1517 However, the
studies on corneal epithelial cells are limited. Previously, we have
showed that protein tyrosine phosphorylation of intracellular
junctional proteins plays an important role in the barrier function
of bovine corneal endothelial cells, as well as controlling corneal
endothelial proliferation.16,17 However, little information is avail-
able about the effect of protein tyrosine phosphorylation in con-
trolling the integrity of cell junction in corneal epithelial cells.
Therefore, in this study, we aimed at investigating the role of pro-
tein tyrosine phosphorylation in controlling the integrity of cell
junction and intracellular permeability in bovine epithelial cells.
Sodium orthovanadate was used to induce general inhibition of
PTPs in this study.
2. Materials and methods
2.1. Antibodies and reagents
Polyclonal rabbit-anti-human p120, polyclonal rabbit anti-
human a-catenin antibody, ﬂuorescein isothiocyanate (FITC)-con-
jugated goat-anti-rabbit and goat-anti-mouse antibodies, horse-
radish peroxidase-conjugated goat-anti-rabbit antibody, and goat
anti-mouse antibody were purchased from Santa Cruz Bio-
technology Inc. (Santa Cruz, CA). Monoclonal mouse anti-b-actin
antibody was purchased from Sigma-Aldrich (St. Louis, MO). Rabbit
polyclonal anti-ZO-1, anti-ZO-2, anti-occludin, and anti-
phosphotyrosine antibodies were purchased from Zymed Labora-
tories (San Francisco, CA). Sodium orthovanadate was purchased
from Sigma-Aldrich (St. Louis, MO) and was prepared as a 0.1M
stock solution (pH 7). Mounting medium containing propidium
iodide was purchased from Vector Laboratories (Burlingame, CA).
Dulbecco’s modiﬁed Eagle’s medium (DMEM), penicillin, strepto-
mycin, Fungizone, trypsineethylenediaminetetraacetic acid,
and fetal bovine serum (FBS) were purchased from GIBCO (Grand
Island, NY).
2.2. Culture of bovine corneal epithelial cells
Bovine corneal epithelial cells were prepared as described pre-
viously.18 In brief, bovine cornea was isolated from the eyeball and
immersed with 1.2 U/mL dispase II at 37 C for 1 hour, following
which the epithelial layer was gently isolated. The suspended cells
were cultured with DMEM-F12 containing 1% insulinetransferrine
selenium supplement, 10% FBS, penicillin, streptomycin, and
amphotericin B. Cultured epithelium cells with two passages were
used for the experiments. Conﬂuent cells were treated with 0, 25,
50, and 100 mM sodium orthovanadate for different periods of time.
2.3. MTS assay
Corneal epithelial cells were cultured at a density of 1104 cells
in 96-well plates and allowed to reach conﬂuence. Corneal epi-
thelial cells were treatedwith 0, 25, 50, and 100 mMvanadate for 24
and 48 hours. At the end of experiments, cell viability was eval-
uated using CellTiter 96 AQueous One Solution Reagent (Promega,
Madison, WI) according to the manufacturer’s instructions. In brief,
the medium was removed, and MTS/phenazine methosulfatesolution was added. After incubating at 37 C for 2 hours, cell via-
bility was determined by measuring the absorbance at 490 nm
using an enzyme-linked immunosorbent assay reader. All experi-
ments were repeated six times to ensure consistent results. In all
experiments, only vehicle without adding sodium orthovanadate
was used as control.2.4. Immunocytochemical localization
Conﬂuent cells treated with different concentrations of sodium
orthovanadate were ﬁxed in 10% natural formalin followed by
permeabilization with 0.4% Triton X-100. Subsequently, cells were
blocked by 1% FBS in phosphate-buffered saline (PBS) at 37 C for 1
hour followed by incubation with primary antibodies at 4 C
overnight. Concentrations of primary antibodies were all 1:100.
Subsequently, a 1:100 diluted solution of the appropriate FITC-
conjugated secondary antibodies was added. All the experiments
were repeated three times to ensure consistent results. Positive
staining was visualized using a Leica TCS SP2 confocal laser scan-
ning microscope (Leica Microsystems, Heidelberg, Germany). In all
experiments, only vehicle without adding sodium orthovanadate
was used as control.2.5. Protein extraction and immunoblotting
The cultured cells grown were trypsinized, suspended in buffer
containing 1% Triton X-100, 250 mM NaCl, 2 mM EDTA, 50 mM
TriseHCl, 10 mg/mL leupeptin, and 1 mM phenylmethylsulfonyl
ﬂuoride (all from Sigma), and homogenized. Equal amounts of
extracted protein were loaded on 4e12% polyacrylamide gels
(Invitrogen, Carlsbad, CA) for sodium dodecyl sulfate poly-
acrylamide gel electrophoresis analysis. After electrophoresis,
proteins were transferred to polyvinylidene diﬂuoride membranes
(Millipore Corporation, Bedford, MA), and then incubated at room
temperature for 2 hours with antibodies against p120, a-catenin,
ZO-1, ZO-2, and occludin. Anti-b-actin was used as an internal
control. Membranes were then incubated with horseradish
peroxidase-conjugated secondary antibody at a ﬁnal dilution of
1:1000. After a ﬁnal washing with 0.1% Triton X-100 in PBS, ﬂuo-
rescent signals were detected by enhanced chemiluminescence
following the manufacturer’s instructions (Pierce, Rockford, IL,
USA) and exposed to autoradiographic ﬁlm. All experiments were
repeated three times to ensure consistent results. In all experi-
ments, only vehicle without adding sodium orthovanadate was
used as a control.2.6. Measurement of transepithelial electrical resistance
Bovine corneal epithelial cells were seeded in the upper
chamber of Costar Transwell (1.12 cm2 diameter, 0.4 mm pore size)
and allowed to reach conﬂuency. Transepithelial electrical resist-
ance (TER) was measured using a Millicell-ERS electrical resistance
system (Millipore, Bedford, MA) and calculated as Ucm2 by multi-
plying it with the surface area of the monolayer (1.12 cm2). The
resistance of the supporting membrane in Transwell ﬁlters is sub-
tracted from all readings before performing the calculations. Cells
were used for further study only if the TER value was more than
30 Ucm2. TER was measured at 0, 24, and 48 hours after adding
vanadate. At the indicated time points, the TER value wasmeasured
and transformed to a percentage compared with the value at hour
0. All experiments were repeated six times to ensure consistent
results. In all experiments, only vehicle without adding sodium
orthovanadate was used as control.
Fig. 2. MTS assay. The effect of sodium orthovanadate on cell viability of the conﬂuent
bovine corneal epithelial cells. There was no signiﬁcant cellular apoptosis at 24 and 48
hours after the treatment of vanadate with different concentrations. Standard error of
the mean was used instead of standard deviation. SOV ¼ sodium orthovanadate.
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Experimental data were analyzed using one-way analysis of
variance. The results are expressed as the mean  standard error of
the mean. A p value <0.05 was considered to be statistically
signiﬁcant.
3. Results
3.1. Time-dependent effect of PTP inhibition on tyrosine
phosphorylation of the intercellular boundaries of corneal epithelial
cells
Effects of sodium orthovanadate on tyrosine phosphorylation of
bovine corneal epithelial cells were evaluated by immunocy-
tochemical (ICC) analysis, the result of which showed a time-
dependent response of protein tyrosine phosphorylation on cell
borders from 0, 5, 15, 30, 60, 120 minutes to 24 and 48 hours after
treatment (Fig. 1).
3.2. Conditions of PTP inhibition in this study did not cause cellular
death in postconﬂuent bovine corneal epithelial cells
To conﬁrm that no signiﬁcant cellular death was found under
the treatment proﬁle, an MTS assay was performed, the results of
which showed that sodium orthovanadate concentration was only
25, 50, or 100 mM after treatment for 24 or 48 hours, and there was
no signiﬁcant change of MTS results (Fig. 2).
3.3. PTP inhibition disrupted junctional proteins in postconﬂuent
bovine corneal epithelial cells in a time- and dose-dependent
manner
Fig. 3 demonstrated that sodium orthovanadate can induce
a trend of time- and dose-dependent disruption of cell junctional
proteins, including ZO-1, ZO-2, a-catenin, p120, and occludin.
3.4. PTP inhibition did not change the expression amount of
junctional proteins
We examined the expression amount of junctional proteins af-
ter inhibition of PTP by Western blot analysis, and found thatFig. 1. Effect of sodium orthovanadate on tyrosine phosphorylation of bovine corneal epithel
orthovanadate for (A) 0, (B) 5, (C) 15, (D) 30, (E) 60 and (F) 120 minutes, and (G) 24 and (H) 4
induced in a time-dependent manner. Blue ¼ 40 ,6-diamidino-2-phenylindole staining of thirrespective of ZO-1, p120, or occludin, the expression levels were
the same under various treatment conditions (Fig. 4).3.5. PTP inhibition induced dose- and time-dependent decrease of
transepithelial electric resistance on postconﬂuent bovine corneal
epithelial cells
At 12 and 24 hours after sodium orthovanadate treatment, sig-
niﬁcant dose- and time-dependent decrease of TER was found
(Fig. 5), which was consistent with the disrupting effects of sodium
orthovanadate on adherens-type junctional proteins evaluated by
ICC (Fig. 3).4. Discussion
The inhibition of PTP was conﬁrmed to increase tyrosine phos-
phorylation of proteins almost exclusively restricted to the cellecell
borders. Quite a few studies conﬁrmed that it decreased both celle
cell tight junctions and adherens-type junctional integrity.19,20
Other studies demonstrated that tyrosine phosphorylation of
adherens-type junctional proteins by PTP inhibition can reduce
cellecell junctional integrity and open the vascular endothelial
paracellular pathways.2124 Previously, we demonstrated thatium evaluated by immunocytochemical analysis. Cells were treated with 50 mM sodium
8 hours before performing immunoﬂuorescent staining. Tyrosine phosphorylation was
e nuclei; green ¼ protein tyrosine phosphorylation mainly on cell borders.
Fig. 3. Effect of sodium orthovanadate on intercellular junctional proteins of bovine corneal epithelium evaluated by immunocytochemical analysis. Cells were treated with 25, 50,
and 100 mM of SOV at 24 and 48 hours. A trend of time- and dose-dependent disruption of the junctional proteins was found on ZO-1, ZO-2, a-catenin, p-120, and occludin. In all
experiments, only vehicle without adding sodium orthovanadate was used as control. Blue ¼ 40 ,6-diamidino-2-phenylindole staining of the nuclei; green ¼ junctional proteins;
SOV ¼ sodium orthovanadate.
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mote time-dependent increase in protein tyrosine phosphorylation
and cellecell junctional disruption in postconﬂuent bovine corneal
endothelial cells.17 Adherens-type junction-associated proteins,
including p120 and a-catenin, were found to be disrupted from
their original locations after treatment. Sodium orthovanadate also
decreased TER in a time- and dose-dependent manner, which
conﬁrmed that the cellular junctions were disrupted.17
Although the role of PTP in controlling cellecell junctional
integrity has been conﬁrmed in many cell types including corneal
endothelial cells, its role in corneal epithelial cells has seldom been
studied before. The integrity of corneal epithelial cells is extremely
important because they play a central role in preventing pathogen
invasion and corneal overhydration from precorneal tear ﬁlms. TheFig. 4. Effect of protein tyrosine phosphatase inhibition with vanadate on the
expression level of intracellular junctional proteins in conﬂuence bovine epithelial
cells evaluated by Western blot analysis. There was no signiﬁcant change of junctional
proteins ZO-1, p120, and occludin after treatment with 25, 50, or 100 mM of sodium
orthovanadate for 24 or 48 hours. In all experiments, only vehicle without adding
sodium orthovanadate was used as control. SOV ¼ sodium orthovanadate.results of this study conﬁrm that, as with many other cell types,
nonselective PTP inhibition with sodium orthovanadate induced
time-dependent increase of protein tyrosine phosphorylation of
cell junctional proteins in corneal epithelial cells. Several adherens-
type junctional proteins such as p120, a-catenin, and tight junc-
tional proteins such as occludin, ZO-1, and ZO-2 were involved.
Such a phenomenon was further conﬁrmed by TER, which showed
time- and dose-dependent decrease of electric resistance after so-
dium orthovanadate treatment.
In conﬂuent corneal endothelial cells, we have shown that
nonselective PTP inhibition can disrupt cellecell junctions, and
trigger contact-inhibited rat, but not bovine, corneal endothelial
cells to proliferate.16,17 In these previous studies, the Ki-67-positive
rat corneal endothelial cells could be found after sodiumFig. 5. The effect of protein tyrosine phosphatase inhibition on transepithelial electric
resistance (TER) on conﬂuent bovine epithelial cells. SOV induced dose- and time-
dependent decrease of TER at 24 and 48 hours after treatment. Standard error of the
meanwas used instead of standard deviation. * p < 0.05. SOV ¼ sodium orthovanadate.
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from corneal endothelial cells, the stem cells of corneal epithelial
cells reside in the limbal region.2528 Although terminally differ-
entiated squamous corneal epithelial cells lost their proliferative
capacity, the basal corneal epithelial cells may still have limited
proliferative capacity andwere thus deﬁned as transient amplifying
cells (TACs).2933 Whether the contact inhibition controlled by PTP
plays a role in controlling the proliferative capacity of corneal
epithelial stem cells or TACs needs to be evaluated.
This study evaluated the general role of phosphatase function in
controlling the integrity of cellecell junctions and permeability in
corneal epithelial cells. Although the underlying mechanism for the
control systemisnot clearlyknownyet, this studystill opensupanew
avenue for further investigation and leads to a greater understanding
of the speciﬁc mechanisms regulating the cellular junction and per-
meability in corneal epithelial cells. In clinical considerations, such
ﬁndings can broaden our knowledge of the corneal epithelial physi-
ology, and potentially lead to pharmacological applications.
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